Interferon gamma/IFNγ Mouse mAb

抗体

干扰素γ抗体 | 干扰素γ单克隆抗体 | 干扰素γ包被抗体 | Interferon gamma抗体 | Interferon gamma单克隆抗体 | Interferon gamma包被抗体 | IFNγ抗体 | IFNγ单克隆抗体 | IFNγ包被抗体 | IFNG抗体 | IFNG单克隆抗体 | IFNG包被抗体

IF 1 antibody | IFG antibody | IFI antibody | ifn g antibody | IFN gamma antibody | IFN immune antibody | IFN, immune antibody | IFN-gamma antibody | IFNG antibody | IFNG_HUMAN antibody | Immune interferon antibody | Interferon gamma antibody | Type II In

Liquid

Ab110997-10μg

10μg

≥95%(SDS-PAGE)

-20°C储存,避免反复冻融

超低温冰袋运输

长期储存-20℃（36个月）；收货后建议分装，避免反复冻融。

10mM PBS, 0.2% ProClin 300, pH 7.4

0.2% ProClin 300

Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. Post-translational: Proteolytic processing produces C-terminal heterogeneity, with proteins ending alternatively at Gly-150, Met-157 or Gly-161.

Recombinant Interferon gamma protein.

小鼠(Mouse)

人(Human)

IFNG

WB: Wild-type Jurkat Treated: PMA (25 ng/mL, 6 h) and ionomycin (1 ug/mL, 6 h), BFA (5 ug/ml, last 5 h) cell lysate. Flow Cyt (intra): PBMC cells treated with cell stimulation cocktail (80nM PMA+1.34µM Ionomycin+10.6µM BFA+2uM Monensin).

150 kDa

Unconjugated

Mouse IgG2b

单克隆抗体

Protein G purified

22G5

[Ab110992] Recombinant Interferon gamma/IFNγ Antibody as Detection antibody in ELISA, CLIA, Luminex xMAP

Whole IgG